These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15882516)
21. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597 [TBL] [Abstract][Full Text] [Related]
23. Elevated lipolysis in adipose tissue by doxorubicin via PPARα activation associated with hepatic steatosis and insulin resistance. Renu K; K B S; Parthiban S; S S; George A; P B TP; Suman S; V G A; Arunachalam S Eur J Pharmacol; 2019 Jan; 843():162-176. PubMed ID: 30452912 [TBL] [Abstract][Full Text] [Related]
24. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Oliveira CP; Coelho AM; Barbeiro HV; Lima VM; Soriano F; Ribeiro C; Molan NA; Alves VA; Souza HP; Machado MC; Carrilho FJ Braz J Med Biol Res; 2006 Feb; 39(2):189-94. PubMed ID: 16470305 [TBL] [Abstract][Full Text] [Related]
25. From the metabolic syndrome to NAFLD or vice versa? Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease. Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885 [TBL] [Abstract][Full Text] [Related]
27. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330 [TBL] [Abstract][Full Text] [Related]
28. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model. Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480 [TBL] [Abstract][Full Text] [Related]
29. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Begriche K; Igoudjil A; Pessayre D; Fromenty B Mitochondrion; 2006 Feb; 6(1):1-28. PubMed ID: 16406828 [TBL] [Abstract][Full Text] [Related]